Literature DB >> 29097394

Mycobacteria exploit nitric oxide-induced transformation of macrophages into permissive giant cells.

Kourosh Gharun1,2, Julia Senges1, Maximilian Seidl1,3, Anne Lösslein1, Julia Kolter1,2, Florens Lohrmann1,4,5, Manfred Fliegauf1, Magdeldin Elgizouli1, Marco Alber, Martina Vavra6, Kristina Schachtrup1, Anna L Illert7,8, Martine Gilleron9, Carsten J Kirschning10, Antigoni Triantafyllopoulou1,5, Philipp Henneke11,12.   

Abstract

Immunity to mycobacteria involves the formation of granulomas, characterized by a unique macrophage (MΦ) species, so-called multinucleated giant cells (MGC). It remains unresolved whether MGC are beneficial to the host, that is, by prevention of bacterial spread, or whether they promote mycobacterial persistence. Here, we show that the prototypical antimycobacterial molecule nitric oxide (NO), which is produced by MGC in excessive amounts, is a double-edged sword. Next to its antibacterial capacity, NO propagates the transformation of MΦ into MGC, which are relatively permissive for mycobacterial persistence. The mechanism underlying MGC formation involves NO-induced DNA damage and impairment of p53 function. Moreover, MGC have an unsurpassed potential to engulf mycobacteria-infected apoptotic cells, which adds a further burden to their antimycobacterial capacity. Accordingly, mycobacteria take paradoxical advantage of antimicrobial cellular efforts by driving effector MΦ into a permissive MGC state.
© 2017 The Authors.

Entities:  

Keywords:  macrophages; multinucleated giant cells; mycobacteria; nitric oxide; p53

Mesh:

Substances:

Year:  2017        PMID: 29097394      PMCID: PMC5709734          DOI: 10.15252/embr.201744121

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  56 in total

Review 1.  The nuclear factor NF-kappaB pathway in inflammation.

Authors:  Toby Lawrence
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-07       Impact factor: 10.005

Review 2.  The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics.

Authors:  Jon O Lundberg; Eddie Weitzberg; Mark T Gladwin
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

3.  The macrophage paradox.

Authors:  Jordan V Price; Russell E Vance
Journal:  Immunity       Date:  2014-11-01       Impact factor: 31.745

4.  Mycobacteria exploit nitric oxide-induced transformation of macrophages into permissive giant cells.

Authors:  Kourosh Gharun; Julia Senges; Maximilian Seidl; Anne Lösslein; Julia Kolter; Florens Lohrmann; Manfred Fliegauf; Magdeldin Elgizouli; Marco Alber; Martina Vavra; Kristina Schachtrup; Anna L Illert; Martine Gilleron; Carsten J Kirschning; Antigoni Triantafyllopoulou; Philipp Henneke
Journal:  EMBO Rep       Date:  2017-11-02       Impact factor: 8.807

5.  ATM phosphorylates histone H2AX in response to DNA double-strand breaks.

Authors:  S Burma; B P Chen; M Murphy; A Kurimasa; D J Chen
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

6.  Induction of serine protease inhibitor 9 by Mycobacterium tuberculosis inhibits apoptosis and promotes survival of infected macrophages.

Authors:  Zahra Toossi; Mianda Wu; Roxana Rojas; Barbara Kalsdorf; Htin Aung; Christina S Hirsch; Jessica Walrath; Angela Wolbink; Marieke van Ham; Richard F Silver
Journal:  J Infect Dis       Date:  2011-11-16       Impact factor: 5.226

7.  p53 Attenuates lipopolysaccharide-induced NF-kappaB activation and acute lung injury.

Authors:  Gang Liu; Young-Jun Park; Yuko Tsuruta; Emmanuel Lorne; Edward Abraham
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

8.  Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions.

Authors:  F Facchetti; W Vermi; S Fiorentini; M Chilosi; A Caruso; M Duse; L D Notarangelo; R Badolato
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

9.  Multinucleated Giant Cells Are Specialized for Complement-Mediated Phagocytosis and Large Target Destruction.

Authors:  Ronny Milde; Julia Ritter; Glenys A Tennent; Andrzej Loesch; Fernando O Martinez; Siamon Gordon; Mark B Pepys; Admar Verschoor; Laura Helming
Journal:  Cell Rep       Date:  2015-11-25       Impact factor: 9.423

10.  Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence.

Authors:  Huixian Gan; Jinhee Lee; Fucheng Ren; Minjian Chen; Hardy Kornfeld; Heinz G Remold
Journal:  Nat Immunol       Date:  2008-09-14       Impact factor: 25.606

View more
  13 in total

1.  Mycobacteria exploit nitric oxide-induced transformation of macrophages into permissive giant cells.

Authors:  Kourosh Gharun; Julia Senges; Maximilian Seidl; Anne Lösslein; Julia Kolter; Florens Lohrmann; Manfred Fliegauf; Magdeldin Elgizouli; Marco Alber; Martina Vavra; Kristina Schachtrup; Anna L Illert; Martine Gilleron; Carsten J Kirschning; Antigoni Triantafyllopoulou; Philipp Henneke
Journal:  EMBO Rep       Date:  2017-11-02       Impact factor: 8.807

2.  Factors influencing multinucleated giant cell formation in vitro.

Authors:  Kevin L Trout; Andrij Holian
Journal:  Immunobiology       Date:  2019-08-10       Impact factor: 3.144

Review 3.  Macrophage: A Cell With Many Faces and Functions in Tuberculosis.

Authors:  Faraz Ahmad; Anshu Rani; Anwar Alam; Sheeba Zarin; Saurabh Pandey; Hina Singh; Seyed Ehtesham Hasnain; Nasreen Zafar Ehtesham
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

4.  Mycobacterium microti: Not Just a Coincidental Pathogen for Cats.

Authors:  Sophie Peterhans; Patricia Landolt; Ute Friedel; Francisca Oberhänsli; Matthias Dennler; Barbara Willi; Mirjam Senn; Sandro Hinden; Karin Kull; Anja Kipar; Roger Stephan; Giovanni Ghielmetti
Journal:  Front Vet Sci       Date:  2020-12-03

5.  Monocyte progenitors give rise to multinucleated giant cells.

Authors:  Florens Lohrmann; Lisa Scheuermann; Anne Kathrin Lösslein; Kourosh Gharun; Jana Neuber; Julia Kolter; Aaron James Forde; Christian Kleimeyer; Ying Yee Poh; Matthias Mack; Antigoni Triantafyllopoulou; Micah D Dunlap; Shabaana A Khader; Maximilian Seidl; Alexandra Hölscher; Christoph Hölscher; Xue Li Guan; Anca Dorhoi; Philipp Henneke
Journal:  Nat Commun       Date:  2021-04-01       Impact factor: 14.919

6.  The effect of the WKYMVm peptide on promoting mBMSC secretion of exosomes to induce M2 macrophage polarization through the FPR2 pathway.

Authors:  Wenbo Zhao; Junxian Hu; Qingyi He
Journal:  J Orthop Surg Res       Date:  2021-03-03       Impact factor: 2.359

7.  Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer.

Authors:  Paul J Converse; Deepak V Almeida; Rokeya Tasneen; Vikram Saini; Sandeep Tyagi; Nicole C Ammerman; Si-Yang Li; Nicole M Anders; Michelle A Rudek; Jacques H Grosset; Eric L Nuermberger
Journal:  PLoS Negl Trop Dis       Date:  2018-08-13

Review 8.  The Bovine Tuberculoid Granuloma.

Authors:  Mitchell V Palmer; Carly Kanipe; Paola M Boggiatto
Journal:  Pathogens       Date:  2022-01-04

Review 9.  The cell biology of inflammation: From common traits to remarkable immunological adaptations.

Authors:  Helen Weavers; Paul Martin
Journal:  J Cell Biol       Date:  2020-07-06       Impact factor: 10.539

Review 10.  Cellular and molecular actors of myeloid cell fusion: podosomes and tunneling nanotubes call the tune.

Authors:  Ophélie Dufrançais; Rémi Mascarau; Brigitte Raynaud-Messina; Christel Vérollet; Renaud Poincloux; Isabelle Maridonneau-Parini
Journal:  Cell Mol Life Sci       Date:  2021-07-23       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.